Richard Condon, CEO Aspire Pharma, discusses successful leadership
Leading lights
Related Posts
Brainomix’s AI-enabled stroke software endorsed by NICE
The HTA reported that Brainomix 360 improved access to treatment for stroke patients The National Institute of Health and Care Excellence (NICE) has issued guidance […]
Francis Crick researchers reveal pathways linking intestinal inflammation and colitis
Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis The study, published in Nature Immunology, could help identify new ways […]
Oxford Drug Design achieves in vivo validation for novel cancer treatment
Promising results from mouse study lead to expanded trials Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for […]